Characterizing the Demographics of Chronic Pain Patients in the State of Maine Using the Maine All Payer Claims Database
Overview
Affiliations
Background: Chronic pain is currently a significant health problem in the United States. A comprehensive strategy is needed to increase prevention of chronic pain and to improve care for chronic pain patients. However, development of a successful strategy relies, in part, on a better understanding of the demographics and socioeconomics of patients living with chronic pain conditions. The current study was designed to understand the burden of chronic pain in the state of Maine by identifying the prevalence of chronic pain and its relationship with selected demographic and socioeconomic factors in Maine.
Methods: The Maine All Payer Claims Database (MEAPCD) (2006-2011) was used in the secondary data analysis to assess the demographic characteristics (such as age, sex, insurance type, and county of residence) of chronic pain patients in Maine. Chronic pain patients were identified based on the presence of pre-identified chronic pain-associated ICD-9 code(s) and opioid prescription information. Potential associations between the prevalence of chronic pain and a number of socioeconomic factors were determined by comparisons to Maine Census data.
Results: More women in the state were identified as having chronic pain across all counties and all age groups (> 10 years old). Surprisingly, the majority of chronic pain patients were identified based on the diagnostic code criteria and not the opioid prescription criteria. A greater utilization of public health insurance was seen within the chronic pain patients. At the county level, although neither education level nor income were associated with the prevalence of chronic pain, these factors significantly correlated with the usage of public health insurance.
Conclusions: Further detailed characterization of the chronic pain patient population in the state of Maine, using multiple data sources, can help design population-targeted strategies to prevent and manage chronic pain.
Discordance between preclinical and clinical testing of Na V 1.7-selective inhibitors for pain.
Yang J, Xie Y, Smith R, Ratte S, Prescott S Pain. 2025; 166(3):481-501.
PMID: 39928833 PMC: 11808711. DOI: 10.1097/j.pain.0000000000003425.
Emerging trends in cannabis administration for women with chronic pain.
Cameron E, Jacquin K Mental Health Sci. 2025; 2(4.
PMID: 39816373 PMC: 11735029. DOI: 10.1002/mhs2.88.
Association of Risk Factors and Comorbidities With Chronic Pain in the Elderly Population.
Mookerjee N, Schmalbach N, Antinori G, Thampi S, Windle-Puente D, Gilligan A J Prim Care Community Health. 2024; 15():21501319241233463.
PMID: 38366930 PMC: 10874592. DOI: 10.1177/21501319241233463.
Falasinnu T, Nguyen T, Jiang T, Tamang S, Chaichian Y, Darnall B J Rheumatol. 2023; 51(3):297-304.
PMID: 38101917 PMC: 10922235. DOI: 10.3899/jrheum.2023-0416.
The relationship between chronic diseases and the intensity and duration of low back pain.
Alsubaie S, Alkathiry A, Aljuaid M, Alnasser M Eur J Phys Rehabil Med. 2023; 60(1):55-61.
PMID: 38059574 PMC: 10938039. DOI: 10.23736/S1973-9087.23.07649-9.